Advanced bio-printing platforms that improve the reproducibility, scalability and translational potential of living-cell constructs. This briefing highlights the opportunity at a practical level; the official topic conditions remain binding.
Bio-printing of living cells for regenerative medicine
Advanced bio-printing platforms that improve the reproducibility, scalability and translational potential of living-cell constructs.
Core intervention logic
- 1Define the medical needAdvance living-cell printing technologies and enabling materials
- 2Develop the printing platformDemonstrate functional constructs in well-defined medical applications
- 3Validate function and qualityAddress reproducibility, quality, scale-up and translational readiness
- 4Plan translation and scale-upAdvance living-cell printing technologies and enabling materials
How the action works
Define the medical need
More reliable and clinically useful regenerative-medicine solutions.
Who is it for?
Regenerative-medicine and tissue-engineering researchers; Bio-printing, biomaterials and manufacturing specialists; Clinical teams, SMEs and regulatory experts. The strongest consortia will connect these capabilities around a clearly defined need rather than assemble partners only to satisfy formal eligibility.
What does the call support?
Advance living-cell printing technologies and enabling materials.
Demonstrate functional constructs in well-defined medical applications.
Address reproducibility, quality, scale-up and translational readiness.
What are the key requirements?
- A credible unmet need and clinically relevant validation pathway
- Integration of biology, engineering, manufacturing and quality control
- Early consideration of standards, regulation, ethics and exploitation
- Action type: Research and Innovation Action (RIA).
A competitive proposal must connect the topic’s expected outcomes to a focused intervention logic, credible partners, measurable results and a convincing route to uptake. Scope, eligibility and all special conditions should be checked against the official topic text before consortium commitments are made.
Timeline and next steps
The topic is scheduled to open on 2 June 2027 and the deadline is 22 September 2027. Prospective applicants should use the preparation period to confirm fit, shape the core concept, identify the capabilities required and build the work plan around the expected outcomes.
EXELIXIS can support call interpretation, concept positioning, consortium architecture, proposal development, impact pathways and coordination of partner contributions.
Official sources
This briefing is an original summary prepared from official EU sources. It is provided for orientation and does not replace the binding call text, General Annexes or Funding & Tenders Portal conditions.